Skip to main content

Table 3 Comparison of EC50 values (μM) of DT320 vs conventional agents on different cancer cell lines

From: Identification of novel drugs to target dormant micrometastases

Cell Line

DT320

DT320

Conventional agent

Conventional agent

 

SISgel

Monolayer

SISgel

Monolayer

MDA-MB-231 (breast)

8.7 ± 1.1

78.1 ± 7.1

47.8 ± 4.0 (D)

45.4 ± 1.9 (D)

PC-3 (prostate)

19.7 ± 2.0

41.5 ± 4.1

102.2 ± 7.0 (D)

104.1 ± 6.1 (D)

J82 (bladder)

30.9 ± 4.8

71.2 ± 8.1

>300 (C)

102.3 ± 10.2 (C)

Capan-1 (pancreatic)

22.9 ± 4.8

80.1 ± 10.2

83.1 ± 10.7 (G)

78.2 ± 9.8 (G)

  1. Data represent n = 6-8 from three separate experiments. D = doxorubicin, G = gemcitabine, C = cisplatin